Monsanto Loses Roundup Cancer Trial to the Tune of $80 Million

By Tom McKay
Roundup on sale in San Francisco on Feb. 25, 2019. Photo: Haven Daley (AP)
A federal jury in California has awarded $80 million to a man who said Monsanto herbicide Roundup was a “substantial factor” in him developing non-Hodgkin lymphoma, CNN reported on Wednesday. It’s a major blow to the chemical manufacturer and its parent company, German chemical giant Bayer AG, which are facing hundreds of lawsuits related to the glyphosate-based herbicide in San Francisco.

Comments